SML4035

CGP 78608 hydrochloride

Name: CGP 78608 hydrochloride
Brand: SIGMA

≥97%

동의어(들):

CGP 78608 hydrochloride, CGP-78608 hydrochloride, CGP78608 hydrochloride, PAMQX hydrochloride, [(1S)-1-[[(7-Bromo-1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]amino]ethyl]phosphonate, hydrochloride, P-[(1S)-1-[[(7-Bromo-1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]amino]ethyl]phosphonic acid, hydrochloride (1:1)

조직 및 계약 가격을 보려면 로그인를 클릭합니다.

크기 선택

제품정보 (DICE 배송 시 비용 별도)

실험식(Hill 표기법):

C₁₁H₁₃BrN₃O₅P·HCl

CAS 번호:

1135278-54-4

Molecular Weight:

414.58

MDL number:

MFCD06798371

NACRES:

NA.21

Assay:

≥97%

Form:

powder

Quality level:

100

Storage condition:

desiccated

주요 문서

모든 문서 보기

기술 서비스

도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.

도움 문의

기술 서비스

도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.

도움 문의

제품 이름

CGP 78608 hydrochloride, ≥97%

SMILES string

BrC1=CC(NC2=O)=C(C(CN[C@@H](P(O)(O)=O)C)=C1)NC2=O.Cl

assay

≥97%

form

powder

storage condition

desiccated

color

white to beige

solubility

DMSO: 2 mg/mL, clear (warmed)

storage temp.

-10 to -25°C

Quality Level

100

Biochem/physiol Actions

Potent glycine site-selective NMDA receptor antagonist with anticonvulsant efficacy in vivo.
CGP 78608 (PAMQX) is a potent glycine site-selective NMDA receptor antagonist (IC50 = 5 nM by competitive binding against 5 nM [3H]MDL 105,519; IC50 = 3/2.7 μM against AMPA/kainate, >10 μM against CGP39653 (glutamate site) and channel blocker MK-801) that exhibits anticonvulsant efficacy in mice in vivo (electroshock-induced convulsion ED50 = 12 mg/kg i.p.).